• Current COVID-19 surveillance strategies, as recommended by the World Health Organization (WHO), may be underestimating the real burden of the disease. • A clinical definition taking into account anosmia as a diagnostic symptom increases the sensitivity of the WHO clinical definition. • The proposed clinical definition can complement existing COVID-19 surveillance measures particularly in resource-poor settings where testing and contact tracing capacities are limited.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315965 | PMC |
http://dx.doi.org/10.1016/j.ijid.2020.06.068 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!